Estados financieros detallados de DiaMedica Therapeutics Inc. (DMAC): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto 0.0%, margen operativo 0.0%, margen neto 0.0%.
Al precio actual de $6.63, DMAC presenta beneficios negativos (P/E no significativo) y un ROE del -77.68%. La capitalización bursátil es de $357M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | 0 | 0 | $500000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Coste de Ventas | $2211 | $4000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Bruto | -$2211 | -$4000 | $500000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| I+D | $1.8M | $3.2M | $4.5M | $7.9M | $8.2M | $8.8M | $7.8M | $13.1M | $19.1M | $24.6M |
| Generales y Administrativos | $718045 | $1.3M | $2.7M | $3.7M | $4.5M | $4.9M | $6.2M | $8.2M | $7.6M | $9.8M |
| Gastos Operativos | $2.5M | $4.3M | $7.3M | $11.6M | $12.7M | $13.6M | $14.0M | $21.3M | $26.7M | $34.4M |
| Beneficio Operativo | -$2.5M | -$4.5M | -$6.8M | -$11.6M | -$12.7M | -$13.6M | -$14.0M | -$21.3M | -$26.7M | -$34.4M |
| EBITDA | -$2.1M | -$4.3M | -$5.6M | -$11.6M | -$12.7M | -$13.5M | -$13.6M | -$19.3M | -$24.4M | -$32.7M |
| Gastos por Intereses | $48375 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$2.2M | -$4.3M | -$5.7M | -$10.6M | -$12.3M | -$13.6M | -$13.6M | -$19.3M | -$24.4M | -$32.7M |
| Impuestos | $22314 | -$9000 | $80000 | $31000 | $27000 | $28000 | $28000 | $43000 | $30000 | $28000 |
| Beneficio Neto | -$2.2M | -$4.3M | -$5.7M | -$10.6M | -$12.3M | -$13.6M | -$13.7M | -$19.4M | -$24.4M | -$32.8M |
| BPA | $-0.47 | $-0.72 | $-0.74 | $-0.89 | $-0.78 | $-0.65 | $-0.52 | $-0.60 | $-0.60 | $-0.70 |
| BPA Diluido | $-0.47 | $-0.72 | $-0.74 | $-0.89 | $-0.78 | $-0.65 | $-0.52 | $-0.60 | $-0.60 | $-0.70 |
| Acciones en Circulación (Diluidas) | $4.7M | $5.9M | $7.7M | $12.0M | $15.7M | $20.8M | $26.4M | $32.6M | $40.4M | $47.0M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | 0 | 0 | 0 | 0 |
| Beneficio Bruto | 0 | 0 | 0 | 0 |
| Beneficio Operativo | -$9.0M | -$9.2M | -$10.5M | -$10.1M |
| EBITDA | -$8.6M | -$8.7M | -$10.0M | -$9.8M |
| Beneficio Neto | -$8.6M | -$8.7M | -$10.0M | -$10.1M |
| BPA | $-0.17 | $-0.17 | $-0.19 | $-0.19 |
| BPA Diluido | $-0.17 | $-0.17 | $-0.19 | $-0.19 |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $1.7M | $1.4M | $16.8M | $3.9M | $7.4M | $4.7M | $4.7M | $4.5M | $3.0M | $15.6M |
| Inversiones a Corto | 0 | 0 | 0 | $4.0M | $20.1M | $40.4M | $28.8M | $48.4M | $41.1M | $44.2M |
| Cuentas por Cobrar | $51974 | $80000 | $646000 | $823000 | 0 | 0 | $82000 | $369000 | $236000 | $258000 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $1.9M | $1.5M | $18.0M | $8.8M | $27.9M | $45.4M | $33.8M | $53.7M | $44.6M | $60.6M |
| Inmovilizado Material | $19395 | $37000 | $96000 | $217000 | $174000 | $112000 | $560000 | $485000 | $427000 | $342000 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $1.9M | $1.8M | $18.3M | $9.1M | $28.1M | $45.6M | $34.4M | $54.2M | $46.3M | $61.4M |
| Cuentas por Pagar | $250000 | $513000 | $483000 | $182000 | $1.1M | $509000 | $734000 | $926000 | $940000 | $1.5M |
| Deuda a Corto | 0 | 0 | 0 | $60000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $626966 | $1.0M | $1.3M | $1.3M | $2.0M | $1.5M | $2.2M | $2.8M | $5.4M | $5.1M |
| Deuda a Largo | 0 | 0 | $18000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $626966 | $1.0M | $1.3M | $1.4M | $2.1M | $1.5M | $2.6M | $3.1M | $5.6M | $5.3M |
| Reservas | -$46.7M | -$40.2M | -$46.0M | -$56.6M | -$68.9M | -$82.5M | -$96.2M | -$115.6M | -$140.0M | -$172.8M |
| Patrimonio Neto | $1.2M | $799000 | $17.0M | $7.6M | $26.0M | $44.0M | $31.8M | $51.1M | $40.7M | $56.1M |
| Deuda Total | $200459 | 0 | $23000 | $178000 | $118000 | $52000 | $469000 | $400000 | $340000 | $240000 |
| Deuda Neta | -$1.5M | -$1.4M | -$16.8M | -$7.7M | -$27.4M | -$45.1M | -$33.0M | -$52.5M | -$43.8M | -$59.6M |
| Capital Circulante | $1.2M | $491000 | $16.7M | $7.5M | $25.9M | $43.9M | $31.7M | $50.9M | $39.2M | $55.5M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $3.3M | $15.6M | $4.9M | $5.1M |
| Activos Totales | $57.0M | $61.4M | $53.1M | $45.0M |
| Pasivos Totales | $5.4M | $5.3M | $5.8M | $6.7M |
| Patrimonio Neto | $51.6M | $56.1M | $47.2M | $38.3M |
| Deuda Total | $266000 | $240000 | $212000 | $185000 |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$2.2M | -$4.3M | -$5.7M | -$10.6M | -$12.3M | -$13.6M | -$13.7M | -$19.4M | -$24.4M | -$32.8M |
| Amortizaciones | $2196 | $4000 | $15000 | $21000 | $21000 | $24000 | $25000 | $30000 | $39000 | -$899000 |
| Compensación en Acciones | $263310 | $409000 | $620000 | $1.2M | $1.8M | $1.6M | $1.5M | $1.7M | $2.1M | $3.8M |
| Cambio en Capital Circulante | -$918450 | -$44000 | -$636000 | $387000 | $1.2M | -$461000 | $585000 | $93000 | $1.5M | $675000 |
| Flujo de Caja Operativo | -$3.0M | -$3.9M | -$5.7M | -$9.1M | -$9.2M | -$12.3M | -$11.5M | -$18.7M | -$22.1M | -$29.1M |
| Inversiones (CapEx) | -$6893 | -$22000 | -$50000 | -$2000 | -$47000 | -$22000 | -$81000 | -$24000 | -$25000 | -$40000 |
| Adquisiciones | $1500 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$3.0M | -$3.9M | -$5.7M | -$9.1M | -$9.2M | -$12.3M | -$11.6M | -$18.8M | -$22.1M | -$29.1M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$6.6M | -$7.8M | -$9.1M | -$8.1M |
| Inversiones (CapEx) | -$16189 | -$6000 | -$8000 | -$3000 |
| Flujo de Caja Libre | -$6.6M | -$7.8M | -$9.1M | -$8.1M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | 0 | $1.2M | $822000 | $1.1M |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Ingresos (anual) | | | | -100.0% | | | | | | |
| Crecimiento Beneficio Neto (anual) | | -91.6% | -34.6% | -85.7% | -15.4% | -10.6% | -0.6% | -41.7% | -26.1% | -34.0% |
| Crecimiento BPA (anual) | | -53.2% | -2.8% | -20.3% | +12.4% | +16.7% | +20.0% | -15.4% | +0.0% | -16.7% |
| Cambio en Acciones (anual) | | +25.3% | +30.5% | +54.8% | +30.8% | +32.5% | +27.3% | +23.2% | +24.1% | +16.3% |
| Crecimiento FCF (anual) | | -29.4% | -46.5% | -58.4% | -1.4% | -33.0% | +5.6% | -61.8% | -17.9% | -31.7% |
| Margen Bruto | | | 100.0% | | | | | | | |
| Margen Operativo | | | -1352.2% | | | | | | | |
| Margen EBITDA | | | -1127.8% | | | | | | | |
| Margen Neto | | | -1146.8% | | | | | | | |
| Margen FCF | | | -1149.2% | | | | | | | |
| Tasa Impositiva Efectiva | -1.0% | 0.2% | -1.4% | -0.3% | -0.2% | -0.2% | -0.2% | -0.2% | -0.1% | -0.1% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-0.64 | $-0.66 | $-0.74 | $-0.76 | $-0.59 | $-0.59 | $-0.44 | $-0.58 | $-0.55 | $-0.62 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $4.7M | $5.9M | $7.7M | $12.0M | $15.7M | $20.8M | $26.4M | $32.6M | $40.4M | $47.0M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -77.68% |
| Rentabilidad sobre capital invertido | -100.87% |
| Rentabilidad sobre activos | -83.42% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Salud financiera
| Deuda / Patrimonio | 0.00 |
| Ratio corriente | 6.72 |
| Piotroski F-Score | 2 |
| Altman Z-Score | 37.95 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -4.68 | -6.78 | -3.93 | -5.45 | -13.00 | -5.74 | -3.04 | -4.73 | -9.05 | -11.37 |
| P/VC | 8.36 | 36.25 | 1.32 | 7.63 | 6.11 | 1.76 | 1.31 | 1.81 | 5.39 | 6.66 |
| P/V | 0.00 | 0.00 | 45.07 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Margen Bruto | 0.0% | 0.0% | 100.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Operativo | 0.0% | 0.0% | -1352.2% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Neto | 0.0% | 0.0% | -1146.8% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |